Humanetics Biomed is a Contract Development Manufacturing Organisation (CDMO) that combines the best biomedical technologies from Humanetics; with the technical engineering expertise for research and development of precision lasered components and subcomponents for medical devices.

“Given DSA’s extensive customer base and biomedical expertise, our partnership will enable OpTek to deliver value to new customers in high-growth markets and regions. We look forward to working on complex challenges that can benefit from our applied micromachining and optical fiber processing expertise”

Humanetics Biomed, part of the global industrial technology group Humanetics, is built on 50 years of delivering strain gauge sensors, material processing, laser micromachining, optical fiber processing and fiber optics for its customers from R&D to full scale production volumes. Its customers range from niche start-ups to over 60% of the largest medical companies in the world.

Headquartered in Michigan, Humanetics Biomed operates six manufacturing facilities across the US, Europe (UK), Asia (Sri Lanka and China) with 140,000 sq. ft of facilities and a workforce of 300 people.

Humanetics Biomed’s solutions and applications include:

• Specialty optical fibers, probes, sensors and laser power delivery
• Custom force, load and infusion pump sensors
• Torque transducers used in advanced surgical and orthopaedic tools
• Precision laser machining for stents, hypotubes, ceramics, polymers and rare metals
• Optical fiber processing, stripping, cleaving and lensing
• Turnkey packaging and closed container integrity testing (CCIT)
• Machine automation for scalable and quality controlled process

OpTek, a part of Humanetics Biomed, has agreed to a multi-year strategic agreement with David Schnur Associates (DSA), a global supplier of outsourced technical sales and marketing services for the medical industry. The partnership offers customers a seamless pathway from process validation to full scale production by leveraging OpTek’s 20 years experience in contract manufacturing and precision laser micromachining. OpTek utilises a diverse range of laser wavelengths to provide capabilities including precision micro hole drilling in polymer applications such as microtubing and balloons for filtration and precise drug dosing control.

“To put it in context, laser processing has been at the heart of several of the largest transactions in the medical device OEM space in recent years,” DSA CEO Barry Schnur said. “As medical devices have continued to scale down, there’s been a greater need for precise, tight-tolerance features for complex components in less space, and laser processing is a key technology that has evolved to meet that need.”

“Given DSA’s extensive customer base and biomedical expertise, our partnership will enable OpTek to deliver value to new customers in high-growth markets and regions. We look forward to working on complex challenges that can benefit from our applied micromachining and optical fiber processing expertise,” said Bruce Valentine, OpTek’s Global Managing Director.